Sign in
CompletedPhase 2

A Novel Wearable Device to Improve Sleep Quality

Key facts

Who runs it
University of Utah
Where
Salt Lake City, United StatesSee the site
Trial code
Status
Completed
Phase
Phase 2
People taking part
59 people enrolled
Started
1 Sept 2023
Ended
17 Jul 2024
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Sleep Wellness Device (BeCurie)
Record updated
28 March 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • Clinically elevated insomnia symptoms as defined by Insomnia Severity Index (ISI) score >=15
  • Able to read and write in English
  • Smartphone user

Who cannot take part

  • Prescribed sleep medications or other treatments for insomnia (e.g. cognitive behavioral therapy)
  • Using antipsychotic drugs
  • History of chronic drug or alcohol abuse
  • Diagnosed sleep disorders other than insomnia
  • Untreated or unstable psychiatric disorders as defined by a PHQ8 score of greater than 15
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant
  • A history of serious medical conditions (e.g. cancers, consistent hospitalizations)
  • History of allergy or hypersensitivity to any medical device or its components
  • More than 400mg of caffeine per day
  • Consistent travel across time zones throughout the study period
  • Consistent migraine attacks or headaches
  • Pregnant women or lactating women, or have an infant less than 6 months old
  • Overnight work >1 shift per month

Where in United States

  • University of UtahSalt Lake City, United States

About the trial

What the trial wants to find out

The purpose of the study is to help determine if a wearable sleep wellness device improves sleep among adults with insomnia. This study will enroll a total of 60 participants for this remotly conducted study and randomize 1:1 for treatment and control.

Read full original descriptionShow less

Aim 1 of the study is to test the effects of the sleep wellness device compared to a placebo device on sleep after 28 days of use.

Aim 2 of the study is to test the longer term effects of the sleep wellness device at 3 month follow-up.

The 2 groups in the trial

  • Sleep Wellness DeviceTreatment being tested

    The wearable sleep wellness device that contains specially designed coils that generate micro electromagnetic stimulation located in the neckband and is worn around the neck like headphones for at least 3 hours per day.

    Treatment: Sleep Wellness Device (BeCurie)

  • Inactive Sleep Wellness DeviceSham treatment, for comparison

    This sleep wellness device is running an inactive program in the application (no electromagnetic stimulation).

    Treatment: Sleep Wellness Device (BeCurie)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
28 March 2025